Leading that revolution is the University of Wisconsin-Madison, which in August opened the Transdisciplinary Center for Research in Psychoactive Substances, expanding upon clinical psychedelic studies that have been on campus for seven years. The UW School of Pharmacy is also home to the nation’s first master’s program in psychoactive pharmaceutical investigation, where researchers are studying ketamine’s effects on the brain.
University Communications